Gurgoglione, F.L.; Covani, M.; Torlai Triglia, L.; Benatti, G.; Donelli, D.; Bianconcini, M.; Solinas, E.; Tadonio, I.; Denegri, A.; De Gregorio, M.;
et al. The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence. Life 2025, 15, 1784.
https://doi.org/10.3390/life15111784
AMA Style
Gurgoglione FL, Covani M, Torlai Triglia L, Benatti G, Donelli D, Bianconcini M, Solinas E, Tadonio I, Denegri A, De Gregorio M,
et al. The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence. Life. 2025; 15(11):1784.
https://doi.org/10.3390/life15111784
Chicago/Turabian Style
Gurgoglione, Filippo Luca, Marco Covani, Laura Torlai Triglia, Giorgio Benatti, Davide Donelli, Michele Bianconcini, Emilia Solinas, Iacopo Tadonio, Andrea Denegri, Mattia De Gregorio,
and et al. 2025. "The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence" Life 15, no. 11: 1784.
https://doi.org/10.3390/life15111784
APA Style
Gurgoglione, F. L., Covani, M., Torlai Triglia, L., Benatti, G., Donelli, D., Bianconcini, M., Solinas, E., Tadonio, I., Denegri, A., De Gregorio, M., Dallaglio, G., Dei Cas, A., Bonadonna, R. C., Vignali, L., & Niccoli, G.
(2025). The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence. Life, 15(11), 1784.
https://doi.org/10.3390/life15111784
